Literature DB >> 19523615

Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation.

Ekaterina Plati1, Evangelia Kouskouni, Ariadne Malamitsi-Puchner, Maria Boutsikou, George Kaparos, Stavroula Baka.   

Abstract

OBJECTIVE: To detect the levels of visfatin and leptin in the serum as well as in the follicular fluid (FF) of polycystic ovary syndrome (PCOS) patients undergoing controlled ovarian stimulation and to compare them with the levels found in age- and weight-matched normally ovulating women under IVF treatment.
DESIGN: Prospective study.
SETTING: Assisted Reproduction Unit, Second Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece. PATIENT(S): Forty patients with diagnosed PCOS and 40 age- and weight-matched non-PCOS control women enrolled in the IVF program. INTERVENTION(S): Blood and FF samples were collected from all subjects at oocyte retrieval. MAIN OUTCOME MEASURE(S): Visfatin and leptin levels were measured in serum and FF using ELISA. RESULT(S): Serum visfatin levels were significantly increased in women with PCOS, whereas FF visfatin levels, which were lower than serum levels, did not differ between groups. Serum leptin levels did not differ between groups and were lower than FF levels. CONCLUSION(S): Women with polycystic ovaries exhibit significantly increased serum visfatin and decreased FF leptin levels compared with control subjects of similar age and body mass index, indicating a probable role for visfatin in the general state of insulin resistance and a local contribution in the follicle for leptin in patients undergoing IVF treatment. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523615     DOI: 10.1016/j.fertnstert.2009.04.055

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Correlation of Serum Visfatin Level in Non-obese Women with Polycystic Ovary Syndrome and Matched Control.

Authors:  Alaa Ibrahim Ali; Wassan Nori
Journal:  Reprod Sci       Date:  2022-06-10       Impact factor: 3.060

2.  Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Patricia Luhn; Cher M Dallal; Jocelyn M Weiss; Amanda Black; Wen-Yi Huang; James V Lacey; Richard B Hayes; Frank Z Stanczyk; Nicolas Wentzensen; Louise A Brinton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-21       Impact factor: 4.254

Review 3.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

4.  Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.

Authors:  Fatemeh Farshchian; Fahimeh Ramezani Tehrani; Houshang Amirrasouli; Hooman Rahimi Pour; Mehdi Hedayati; Faranak Kazerouni; Adeleh Soltani
Journal:  Int J Endocrinol Metab       Date:  2014-07-01

5.  Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study.

Authors:  Nadine M P Daan; Maria P H Koster; Marlieke A de Wilde; Gerdien W Dalmeijer; Annemieke M V Evelein; Bart C J M Fauser; Wilco de Jager
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

6.  Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls.

Authors:  Jin Ju Kim; Young Min Choi; Min A Hong; Min Jeong Kim; Soo Jin Chae; Sun Mie Kim; Kyu Ri Hwang; Sang Ho Yoon; Seung Yup Ku; Chang Suk Suh; Seok Hyun Kim
Journal:  Obstet Gynecol Sci       Date:  2018-02-05

7.  Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome.

Authors:  Christian Obirikorang; William K B A Owiredu; Sandra Adu-Afram; Emmanuel Acheampong; Evans Adu Asamoah; Enoch Kwabena Antwi-Boasiakoh; Eddie-Williams Owiredu
Journal:  BMC Res Notes       Date:  2019-08-15

8.  Plasma visfatin levels and mRNA expression of visfatin in peripheral blood mononuclear cells and peripheral blood monocyte-derived macrophages from normal weight females with polycystic ovary syndrome.

Authors:  Jing Zhang; Lingling Zhou; Liulin Tang; Liangzhi Xu
Journal:  Exp Ther Med       Date:  2014-02-18       Impact factor: 2.447

9.  Leptin and body mass index in polycystic ovary syndrome.

Authors:  Nasrin Jalilian; Lida Haghnazari; Samira Rasolinia
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun

10.  Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome.

Authors:  Azadeh Nadjarzadeh; Razieh Dehghani-Firouzabadi; Hoorieh Daneshbodi; Mohammad Hassan Lotfi; Niloofar Vaziri; Hassan Mozaffari-Khosravi
Journal:  J Reprod Infertil       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.